India's Union Health Ministry now requires a doctor's prescription for the purchase of all medicated syrups, including cough syrups [1].
This regulatory shift ends the practice of over-the-counter sales for these medications. The move aims to prevent the unregulated access of syrups that can be misused or abused, while addressing broader public health risks and reports of syrup-related deaths [1], [2].
Under the new rule, pharmacists can no longer sell these products to consumers without a valid medical authorization [3]. This crackdown targets the widespread availability of medicated syrups that were previously accessible without professional medical oversight [3], [4].
The government said the measure is necessary to curb the abuse of specific ingredients found in these syrups [1]. By restricting access to a prescription-only model, the ministry intends to ensure that patients use these medications under the guidance of a licensed healthcare provider [2], [4].
This policy applies nationwide, affecting all pharmacies and drug distributors across India [1], [3]. The ministry is implementing these changes to tighten control over the distribution chain and reduce the incidence of accidental or intentional poisoning associated with unregulated syrup consumption [2], [4].
“India's Union Health Ministry now requires a doctor's prescription for the purchase of all medicated syrups.”
This policy represents a significant tightening of pharmaceutical controls in India. By removing cough syrups from the over-the-counter category, the government is prioritizing the prevention of substance abuse and toxicity over consumer convenience, signaling a more aggressive approach to public health surveillance and drug regulation.
